These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31995000)

  • 1. Renin-Angiotensin-Aldosterone System and Migraine: A Systematic Review of Human Studies.
    Sassi KLM; Martins LB; de Miranda AS; Teixeira AL
    Protein Pept Lett; 2020; 27(6):512-519. PubMed ID: 31995000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
    Gales BJ; Bailey EK; Reed AN; Gales MA
    Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the renin-angiotensin system in migraine.
    Tronvik E; Stovner LJ; Schrader H; Bovim G
    J Hypertens Suppl; 2006 Mar; 24(1):S139-43. PubMed ID: 16601567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine prophylaxis with drugs influencing the renin-angiotensin system.
    Stovner LJ
    Eur J Neurol; 2007 Jul; 14(7):713-4. PubMed ID: 17594324
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders.
    Mohite S; Sanches M; Teixeira AL
    Protein Pept Lett; 2020; 27(6):449-455. PubMed ID: 31868144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis.
    Ripa P; Ornello R; Pistoia F; Carolei A; Sacco S
    Expert Rev Neurother; 2014 Sep; 14(9):1043-55. PubMed ID: 25115162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
    Borghi C; ; Rossi F;
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders.
    Santos SH; Simões e Silva AC
    Curr Clin Pharmacol; 2014 Feb; 9(1):2-9. PubMed ID: 23270435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renin-angiotensin system modulation: instructions for use].
    Bellis A; Rozza F; Crispo S; Trimarco B
    G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers--questions remain unsolved.
    Ueda S
    J Pharmacol Sci; 2010; 113(4):292-5. PubMed ID: 20675956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
    Dalla Vestra M; Simioni N; Masiero A
    Int Urol Nephrol; 2009; 41(1):119-26. PubMed ID: 18958580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.
    Dorosch T; Ganzer CA; Lin M; Seifan A
    Curr Pain Headache Rep; 2019 Sep; 23(11):85. PubMed ID: 31515634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research.
    Ferrario CM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):3-14. PubMed ID: 17083068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.